The growth of Indian IOL manufacturing and the resulting availability of affordable IOLs revolutionized the way ophthalmologists perform cataract surgery in India.

Srinivasan Aravind

“If you look at IOL usage as well as IOL manufacturing, the correlation will be very direct,” Srinivasan Aravind, MS, Aravind Eye Hospitals administrator, told Ocular Surgery News in a telephone interview.

Dr. Aravind and colleagues examined the evolution of cataract surgery in India. They noted that the trend in Indian cataract surgery has moved from intracapsular extraction to manual small-incision extraction with IOL implantation and that the overall number of cataract surgeries performed each year has surged.

“India, in ’93 and ’94, was doing less than a million cataract surgeries a year,” he said.

Today, “in the published records from Vision 2020 India, we are doing 4.8 million surgeries, of which, at least 4 million get IOLs,” he said. “No other country in the world does close to this number.”

The soaring surgery rate is in part due to India’s high incidence of cataract.

“Domestic manufacturing of ophthalmic equipment and IOLs played an important role in bringing down cataract blindness in India,” said Kasthuri N. Ravilla, vice chairman of Appasamy Associates.

The need

Cataract programs, training initiatives and infrastructural development played a role in increasing cataract surgery rates and modernizing techniques, but the transition would not have been possible without lower priced IOLs.

In an article on the large-scale IOL manufacturer Aurolab, managing director P. Balakrishnan, PhD, and colleagues wrote that intracapsular cataract extraction had been the standard of cataract surgery in India for years because affordable IOLs were not available.

Intracapsular extraction was considered unacceptable in developed nations as early as 1984, they said.

“In essence, cataract surgery without the use of an intraocular lens is only half an operation because there is not adequate visual rehabilitation,” they said.

But the Indian ophthalmic community could only move forward with available, affordable IOLs.

In the early 1990s, IOLs were imported to India, carrying the high international prices, Dr. Aravind said.

“The price of PMMA lenses in India was in the range of [Rs. 4,000] and above,” Dr. Balakrishnan said.

Moving forward

In the past 2 decades, many governmental and nongovernmental groups have become involved in cataract surgery in India. have offered grants and infrastructure support and developed surgical quality standards, Dr. Aravind and colleagues said.

“The acceleration took place somewhere in the late ’90s because the government started supporting free eye surgeries” with IOLs, Dr. Aravind said.

One of the key problems these groups initially identified was the lack of affordable, high-quality IOLs.

In 1992, Aravind Eye Care System established Aurolab as a nonprofit public charitable trust. The group would manufacture ophthalmic products for the Aravind Eye Care System.

“The IOL was found to be the costliest consumable item, so Aurolab started with the production of IOLs,” Dr. Balakrishnan said.

Today’s IOL market in India

“Due to the affordability and availability, India has overtaken the [United States], and today is the largest consumer of IOLs in the world,” said Lal Dave, chairman and chief executive officer of EYE O CARE.

Appasamy manufactures 2.5 million IOLs per year, and expect to increase to 3 million in 2008, Mr. Ravilla said.

Dr. Balakrishnan said there are about 150 companies in India manufacturing ophthalmic products, and about 10 produce IOLs. These companies sell IOLs and other products at low prices by fill ing a widespread need. Low costs are offset by high sales, they said.

“Cataract surgery in India fits this profile perfectly because of India’s high prevalence and incidence of cataracts,” they said.

Permeable rigid lenses are the most popular in India, but foldable lenses are gaining ground, Dr. Aravind said.

“For Western manufacturers, hard lenses represent a dead market; in developing countries, however, there is still a large market for hard lenses because the expertise, equipment and funds to support the surgery are often lacking,” Dr. Balakrishnan and colleagues said.

Outside India

India does not require domestically manufactured IOLs to meet ISO standards or European CE Mark standards, but these large companies conform to them in order to compete globally.

“International exports grew significantly after they got the CE mark and other marks,” Dr. Aravind said.

EYE O CARE lenses are ISO- and CE-certified, Mr. Dave said, which has helped international business.

About 40% of EYE O CARE lenses are sold overseas, and 60% of those to developing countries, Mr. Dave said.

Aurolab does about 40% of its business internationally, selling ophthalmic products to more than 120 countries, many of them developing.

“We feel Aurolab and other Indian-made IOLs are primarily responsible for the increase in the volume of IOL surgery in many developing countries,” Dr. Balakrishnan said. “Also, these IOLs are assisting in training more IOL surgeons, which is necessary to increase the surgery rates and volumes.”

A note from the editors:

In regards to advertising, the customary policy of Ocular Surgery News is to have a minimum of four pages between articles that mention a product and an advertisement of the same product. However, because of the number of pages in this issue of OSN India Edition, we had to depart from this policy. The acceptance of advertising in no way influences editorial decisions or content.

The growth of Indian IOL manufacturing and the resulting availability of affordable IOLs revolutionized the way ophthalmologists perform cataract surgery in India.

Srinivasan Aravind

“If you look at IOL usage as well as IOL manufacturing, the correlation will be very direct,” Srinivasan Aravind, MS, Aravind Eye Hospitals administrator, told Ocular Surgery News in a telephone interview.

Dr. Aravind and colleagues examined the evolution of cataract surgery in India. They noted that the trend in Indian cataract surgery has moved from intracapsular extraction to manual small-incision extraction with IOL implantation and that the overall number of cataract surgeries performed each year has surged.

“India, in ’93 and ’94, was doing less than a million cataract surgeries a year,” he said.

Today, “in the published records from Vision 2020 India, we are doing 4.8 million surgeries, of which, at least 4 million get IOLs,” he said. “No other country in the world does close to this number.”

The soaring surgery rate is in part due to India’s high incidence of cataract.

“Domestic manufacturing of ophthalmic equipment and IOLs played an important role in bringing down cataract blindness in India,” said Kasthuri N. Ravilla, vice chairman of Appasamy Associates.

The need

Cataract programs, training initiatives and infrastructural development played a role in increasing cataract surgery rates and modernizing techniques, but the transition would not have been possible without lower priced IOLs.

In an article on the large-scale IOL manufacturer Aurolab, managing director P. Balakrishnan, PhD, and colleagues wrote that intracapsular cataract extraction had been the standard of cataract surgery in India for years because affordable IOLs were not available.

Intracapsular extraction was considered unacceptable in developed nations as early as 1984, they said.

“In essence, cataract surgery without the use of an intraocular lens is only half an operation because there is not adequate visual rehabilitation,” they said.

But the Indian ophthalmic community could only move forward with available, affordable IOLs.

In the early 1990s, IOLs were imported to India, carrying the high international prices, Dr. Aravind said.

“The price of PMMA lenses in India was in the range of [Rs. 4,000] and above,” Dr. Balakrishnan said.

Moving forward

In the past 2 decades, many governmental and nongovernmental groups have become involved in cataract surgery in India. have offered grants and infrastructure support and developed surgical quality standards, Dr. Aravind and colleagues said.

“The acceleration took place somewhere in the late ’90s because the government started supporting free eye surgeries” with IOLs, Dr. Aravind said.

One of the key problems these groups initially identified was the lack of affordable, high-quality IOLs.

In 1992, Aravind Eye Care System established Aurolab as a nonprofit public charitable trust. The group would manufacture ophthalmic products for the Aravind Eye Care System.

“The IOL was found to be the costliest consumable item, so Aurolab started with the production of IOLs,” Dr. Balakrishnan said.

Today’s IOL market in India

“Due to the affordability and availability, India has overtaken the [United States], and today is the largest consumer of IOLs in the world,” said Lal Dave, chairman and chief executive officer of EYE O CARE.

Appasamy manufactures 2.5 million IOLs per year, and expect to increase to 3 million in 2008, Mr. Ravilla said.

Dr. Balakrishnan said there are about 150 companies in India manufacturing ophthalmic products, and about 10 produce IOLs. These companies sell IOLs and other products at low prices by fill ing a widespread need. Low costs are offset by high sales, they said.

“Cataract surgery in India fits this profile perfectly because of India’s high prevalence and incidence of cataracts,” they said.

Permeable rigid lenses are the most popular in India, but foldable lenses are gaining ground, Dr. Aravind said.

“For Western manufacturers, hard lenses represent a dead market; in developing countries, however, there is still a large market for hard lenses because the expertise, equipment and funds to support the surgery are often lacking,” Dr. Balakrishnan and colleagues said.

Outside India

India does not require domestically manufactured IOLs to meet ISO standards or European CE Mark standards, but these large companies conform to them in order to compete globally.

“International exports grew significantly after they got the CE mark and other marks,” Dr. Aravind said.

EYE O CARE lenses are ISO- and CE-certified, Mr. Dave said, which has helped international business.

About 40% of EYE O CARE lenses are sold overseas, and 60% of those to developing countries, Mr. Dave said.

Aurolab does about 40% of its business internationally, selling ophthalmic products to more than 120 countries, many of them developing.

“We feel Aurolab and other Indian-made IOLs are primarily responsible for the increase in the volume of IOL surgery in many developing countries,” Dr. Balakrishnan said. “Also, these IOLs are assisting in training more IOL surgeons, which is necessary to increase the surgery rates and volumes.”

A note from the editors:

In regards to advertising, the customary policy of Ocular Surgery News is to have a minimum of four pages between articles that mention a product and an advertisement of the same product. However, because of the number of pages in this issue of OSN India Edition, we had to depart from this policy. The acceptance of advertising in no way influences editorial decisions or content.